TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
<h3>Objective</h3><p dir="ltr">Metastatic Leydig cell tumors (LCT) are rare, difficult-to-treat malignancies without known underlying molecular–genetic events. An index case of metastatic LCT showed an <i>LDLR–TERT</i> gene fusion upon routine genetic profilin...
محفوظ في:
| المؤلف الرئيسي: | Bozo Kruslin (10418791) (author) |
|---|---|
| مؤلفون آخرون: | Zoran Gatalica (3353003) (author), Ondrej Hes (5980643) (author), Faruk Skenderi (6616190) (author), Markku Miettinen (415251) (author), Elma Contreras (16561296) (author), Joanne Xiu (5024744) (author), Michelle Ellis (16928736) (author), Elena Florento (16928739) (author), Semir Vranic (3353012) (author), Jeffrey Swensen (4760673) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
TERT gene fusions characterize a subset of metastatic Leydig cell tumors
حسب: Bozo, Kruslin
منشور في: (2021) -
Tumor vasculature vs tumor cell targeting: Understanding the latest trends in using functional nanoparticles for cancer treatment
حسب: Awad, Nahid S.
منشور في: (2023) -
Spinal cord tumor presenting with neck stiffness
حسب: Anood Alassaf (14778064)
منشور في: (2021) -
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
حسب: Belal Chaudhary (19738021)
منشور في: (2016) -
p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells
حسب: Mohamad Harajly (18810850)
منشور في: (2023)